A detailed history of Rothschild Investment LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 205 shares of CDXS stock, worth $338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
205
Previous 205 -0.0%
Holding current value
$338
Previous $500,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$1.97 - $2.64 $265 - $356
135 Added 192.86%
205 $500,000
Q1 2025

Apr 08, 2025

SELL
$2.53 - $5.43 $227 - $488
-90 Reduced 56.25%
70 $188,000
Q4 2024

Feb 04, 2025

BUY
$2.91 - $5.81 $334 - $668
115 Added 255.56%
160 $763,000
Q2 2024

Jul 30, 2024

BUY
$2.65 - $3.92 $119 - $176
45 New
45 $140,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $108M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.